Serum Phosphate Predicts Early Mortality in Adults Starting Antiretroviral Therapy in Lusaka, Zambia: A Prospective Cohort Study
Douglas C. Heimburger, John R. Koethe, Christopher Nyirenda et al. · 2010
Read Serum Phosphate Predicts Early Mortality in Adults Starting Antiretroviral Therapy in Lusaka, Zambia: A Prospective Cohort Study by Douglas C. Heimburger, John R. Koethe, Christopher Nyirenda et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010687.txt.
Description
Douglas Heimburger and colleagues followed adults starting HIV treatment in Lusaka, Zambia, in PLOS ONE in 2010. Death rates run high in the first weeks of antiretroviral therapy in much of Africa. Clinics with few lab tests need simple signs that flag who is in danger.
The team tracked blood phosphate, a cheap and common test, from the start of treatment. Low or falling phosphate marked patients more likely to die early. The link held even after other risk signs were counted. A low-cost flag like this could steer food support and close watching toward the patients who need them most.
Catalog record
| CREATOR | Douglas C. Heimburger, John R. Koethe, Christopher Nyirenda et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010687